Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Abbott Split Up: Who Wins?

Nov 30 2011

Related Content

Abbott Shaves U.S. Pharma Costs With Restructuring

Jan 26 2011

Job One for Big Pharma: Repositioning in DC Post-Health Care Reform

Mar 01 2011

Health Care Reform and Business Development: 10 Reasons it Matters

Oct 01 2009

Abbott Pays $450MM Up-Front For Rights To Reata's CKD Drug

Sep 23 2010

Piramal Deal Done, Abbott's India Plunge May Fetch Big Returns, But Integration Challenges, Growth Momentum Critical

May 24 2010

Abbott Established Products Senior VP Michael Warmuth Stresses Diversified Portfolio In Emerging Markets: An Interview With PharmAsia News (Part 2 of 2)

Aug 22 2011

Taking Lumps From Health Care Reform

Jun 01 2010

Related Companies

Abbott

Pfizer Inc.

Johnson & Johnson

UCB S.A.

Bristol Myers Squibb Company

Biogen, Inc.

Reata Pharmaceuticals, Inc.

Facet Biotech

Neurocrine Biosciences, Inc.

Piramal Enterprises Limited

Eli Lilly and Company

Merck & Co., Inc.

Medco Health Solutions Inc.

Eastman Kodak Co.

Sanofi

Schering-Plough

Knoll Pharmaceutical Co.

Additional Topics

Medical Device BioPharmaceutical

More from Archive

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window